Carmen Canals

Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Anna Sureda, Stephen Robinson, Carmen Canals et al. · Journal of Clinical Oncology · 2007 · 318 citations · Full text

Medicine, Hematology, Oncology +16

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

Jorge Sierra, Waleska S. Pérez, C Rozmán et al. · PubMed · 2002 · 270 citations

Medicine, Hematology, Immunology +14

Allogeneic Stem-Cell Transplantation As Salvage Therapy for Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Relapsing After an Autologous Stem-Cell Transplantation: An Analysis of the European Group for Blood and Marrow Transplantation Registry

Roel J.W. van Kampen, Carmen Canals, Harry C. Schouten et al. · Journal of Clinical Oncology · 2011 · 215 citations · Full text

Medicine, Hematology, Oncology +16

Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Espanol de Linfomas/Trasplante de Medula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Anna Sureda, Carmen Canals, R. Arranz et al. · Haematologica · 2011 · 213 citations · Full text

Medicine, Immunology, Oncology +17

Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Rafael F. Duarte, Carmen Canals, Francesco Onida et al. · Journal of Clinical Oncology · 2010 · 204 citations · Full text

Medicine, Hematology, Oncology +15